- Home
- CNSP vs GAUZ Comparison
CNSP vs GAUZ Comparison
Compare CNSP & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNSP | GAUZ |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 8.1M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CNSP | GAUZ |
|---|---|---|
| Price | $5.22 | $6.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $20.00 | $11.50 |
| AVG Volume (30 Days) | 5.7K | ★ 167.9K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $22.59 |
| Revenue Next Year | N/A | $59.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $0.23 |
| 52 Week High | $10.59 | $8.52 |
Technical Indicators
Market Signals| Indicator | CNSP | GAUZ |
|---|---|---|
| Relative Strength Index (RSI) | 42.31 | 74.25 |
| Support Level | $5.15 | $0.57 |
| Resistance Level | $5.53 | $8.52 |
| Average True Range (ATR) | 0.17 | 0.62 |
| MACD | -0.10 | 0.53 |
| Stochastic Oscillator | 17.56 | 72.68 |
Price Performance
Historical ComparisonAbout CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products products include suspended particle device, or SPD, and liquid crystal, or LC, materials for smart glass applications, and AI-powered advanced driver assistance systems, or ADAS, solutions including camera monitoring systems, or CMS. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries.